313 related articles for article (PubMed ID: 33277309)
1. Opportunities and Challenges in Drug Development for Pediatric Cancers.
Laetsch TW; DuBois SG; Bender JG; Macy ME; Moreno L
Cancer Discov; 2021 Mar; 11(3):545-559. PubMed ID: 33277309
[TBL] [Abstract][Full Text] [Related]
2. New approaches to therapeutic drug development for childhood cancers.
Campbell K; Ma C; DuBois SG
Curr Opin Pediatr; 2020 Feb; 32(1):35-40. PubMed ID: 31790026
[TBL] [Abstract][Full Text] [Related]
3. Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations.
Barry E; Walsh JA; Weinrich SL; Beaupre D; Blasi E; Arenson DR; Jacobs IA
Paediatr Drugs; 2021 Jul; 23(4):381-394. PubMed ID: 34173206
[TBL] [Abstract][Full Text] [Related]
4. Ushering in the next generation of precision trials for pediatric cancer.
DuBois SG; Corson LB; Stegmaier K; Janeway KA
Science; 2019 Mar; 363(6432):1175-1181. PubMed ID: 30872517
[TBL] [Abstract][Full Text] [Related]
5. Evolving paradigms for new agent development in pediatric oncology.
Flynn A; Fox E
Curr Opin Pediatr; 2018 Feb; 30(1):10-16. PubMed ID: 29176356
[TBL] [Abstract][Full Text] [Related]
6. Improving the outcome for children with cancer: Development of targeted new agents.
Adamson PC
CA Cancer J Clin; 2015; 65(3):212-20. PubMed ID: 25754421
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Development of Molecularly Targeted Oncology Drugs.
Patel SK; Leong R; Zhao H; Barone A; Casey D; Liu Q; Burckart GJ; Reaman G
Clin Pharmacol Ther; 2018 Aug; 104(2):384-389. PubMed ID: 29226303
[TBL] [Abstract][Full Text] [Related]
8. Pediatric Cancer Drug Development: Leveraging Insights in Cancer Biology and the Evolving Regulatory Landscape to Address Challenges and Guide Further Progress.
Charlab R; Leong R; Shord SS; Reaman GH
Cold Spring Harb Perspect Med; 2024 Apr; 14(4):. PubMed ID: 38467448
[TBL] [Abstract][Full Text] [Related]
9. Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma.
Moreno L; Barone G; DuBois SG; Molenaar J; Fischer M; Schulte J; Eggert A; Schleiermacher G; Speleman F; Chesler L; Geoerger B; Hogarty MD; Irwin MS; Bird N; Blanchard GB; Buckland S; Caron H; Davis S; De Wilde B; Deubzer HE; Dolman E; Eilers M; George RE; George S; Jaroslav Š; Maris JM; Marshall L; Merchant M; Mortimer P; Owens C; Philpott A; Poon E; Shay JW; Tonelli R; Valteau-Couanet D; Vassal G; Park JR; Pearson ADJ
Eur J Cancer; 2020 Sep; 136():52-68. PubMed ID: 32653773
[TBL] [Abstract][Full Text] [Related]
10. Impact of the biomarker enrichment strategy in drug development.
Lara Gongora AB; Carvalho Oliveira LJ; Jardim DL
Expert Rev Mol Diagn; 2020 Jun; 20(6):611-618. PubMed ID: 31903795
[TBL] [Abstract][Full Text] [Related]
11. Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Pearson AD; Stegmaier K; Bourdeaut F; Reaman G; Heenen D; Meyers ML; Armstrong SA; Brown P; De Carvalho D; Jabado N; Marshall L; Rivera M; Smith M; Adamson PC; Barone A; Baumann C; Blackman S; Buenger V; Donoghue M; Duncan AD; Fox E; Gadbaw B; Hattersley M; Ho P; Jacobs I; Kelly MJ; Kieran M; Lesa G; Ligas F; Ludwinski D; McDonough J; Nikolova Z; Norga K; Senderowicz A; Taube T; Weiner S; Karres D; Vassal G
Eur J Cancer; 2020 Nov; 139():135-148. PubMed ID: 32992153
[TBL] [Abstract][Full Text] [Related]
12. Targeted approaches to childhood cancer: progress in drug discovery and development.
Hirsch S; Marshall LV; Carceller Lechon F; Pearson AD; Moreno L
Expert Opin Drug Discov; 2015 May; 10(5):483-95. PubMed ID: 25840490
[TBL] [Abstract][Full Text] [Related]
13. Bridging Adult Experience to Pediatrics in Oncology Drug Development.
Leong R; Zhao H; Reaman G; Liu Q; Wang Y; Stewart CF; Burckart G
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S129-S135. PubMed ID: 28921643
[TBL] [Abstract][Full Text] [Related]
14. Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master Protocols.
Khan T; Stewart M; Blackman S; Rousseau R; Donoghue M; Cohen K; Seibel N; Fleury M; Benettaib B; Malik R; Vassal G; Reaman G
Ther Innov Regul Sci; 2019 Mar; 53(2):270-278. PubMed ID: 29759018
[TBL] [Abstract][Full Text] [Related]
15. Advancing Drug Development in Gynecologic Malignancies.
Beaver JA; Coleman RL; Arend RC; Armstrong DK; Bala S; Mills GB; Sood AK; Herzog TJ
Clin Cancer Res; 2019 Aug; 25(16):4874-4880. PubMed ID: 31126961
[TBL] [Abstract][Full Text] [Related]
16. Challenges and Opportunities for Childhood Cancer Drug Development.
Houghton PJ; Kurmasheva RT
Pharmacol Rev; 2019 Oct; 71(4):671-697. PubMed ID: 31558580
[TBL] [Abstract][Full Text] [Related]
17. Precision Medicine in Pediatric Oncology.
Vo KT; Parsons DW; Seibel NL
Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314
[TBL] [Abstract][Full Text] [Related]
18. Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Pearson AD; Rossig C; Mackall C; Shah NN; Baruchel A; Reaman G; Ricafort R; Heenen D; Bassan A; Berntgen M; Bird N; Bleickardt E; Bouchkouj N; Bross P; Brownstein C; Cohen SB; de Rojas T; Ehrlich L; Fox E; Gottschalk S; Hanssens L; Hawkins DS; Horak ID; Taylor DH; Johnson C; Karres D; Ligas F; Ludwinski D; Mamonkin M; Marshall L; Masouleh BK; Matloub Y; Maude S; McDonough J; Minard-Colin V; Norga K; Nysom K; Pappo A; Pearce L; Pieters R; Pule M; Quintás-Cardama A; Richardson N; Schüßler-Lenz M; Scobie N; Sersch MA; Smith MA; Sterba J; Tasian SK; Weigel B; Weiner SL; Zwaan CM; Lesa G; Vassal G
Eur J Cancer; 2022 Jan; 160():112-133. PubMed ID: 34840026
[TBL] [Abstract][Full Text] [Related]
19. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine.
Bashraheel SS; Domling A; Goda SK
Biomed Pharmacother; 2020 May; 125():110009. PubMed ID: 32106381
[TBL] [Abstract][Full Text] [Related]
20. Precision medicine in pediatric oncology.
Forrest SJ; Geoerger B; Janeway KA
Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
